• Kiniksa Pharmaceuticals International Chairman and CEO Sanj K. Patel sold 151,300 Class A Ordinary Shares on November 4, 2026.
• Reported sale prices ranged from $92.35 to $96.05 per share.
• Patel also exercised options for 145,763 Class A Ordinary Shares at $17.92 per share that day.
• Following the transactions, he indirectly held 976,643 Class A Ordinary Shares through three trusts.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kiniksa Pharmaceuticals International plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001532218-26-000020), on November 06, 2026, and is solely responsible for the information contained therein.